Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 14, 2015
Purdue University has announced plans to establish a new Pillars of Excellence in the Life Sciences Initiative aimed at enhancing Purdue’s life sciences research and graduate education. The initiative comes as part of Purdue’s recently announced $2 ...
read more
Thursday, August 08, 2019
Purdue has sold its Treyburn, North Carolina, plant to Novo Nordisk for an undisclosed sum, according to an announcement Purdue CEO Craig Landau sent to the plant’s employees.
read more
Thursday, November 19, 2015
Purdue Pharma has announced the appointment of Alan W. Dunton, M.D. to the position of Senior Vice President of Research & Development (R&D) and will report to Chief Executive Officer Mark Timney.
read more
The makers of the potent painkiller OxyContin have pulled out of a federal meeting to review the company's harder-to-abuse version of the much-debated drug.
read more
Purdue Pharma has announced leadership changes to the company’s Board of Directors and Executive Committee effective immediately.
read more
Monday, December 12, 2016
Purdue Pharma L.P. and Exicure, Inc. have announced a strategic research collaboration, option and license agreement to discover and develop a treatment for psoriasis, and other diseases amenable to a gene regulation approach utilizing Exicure’s ...
read more
Puma and Pierre Fabre have entered into an exclusive license agreement under which Pierre Fabre will develop and commercialize NERLYNX® (neratinib) within Europe and part of Africa.
read more
Wednesday, March 20, 2019
Pulse Biosciences announced the appointment of Mitchell Levinson to its board of directors.
read more
Thursday, October 07, 2021
Pulmodyne, Inc., a leading provider of drug atomization delivery, and Alcove Manufacturing and Distribution, Inc., announced the partnership between the two companies to expand distribution, integrate manufacturing, and to continue joint development ...
read more
Pulmatrix and Cipla announced their entry into a Definitive Agreement for the co-development and commercialization of Pulmazole™, an inhaled iSPERSE™ formulation of the anti-fungal drug itraconazole.
read more
Wednesday, September 06, 2017
Pulmatrix has partnered with Vectura Group to develop Pulmatrix's drug candidate, PUR0200, for COPD for the U.S. market.
read more
Pulmatrix has entered into a research collaboration with Nocion Therapeutics to explore new technologies to enable and improve inhaled drug delivery.
read more
Pulmatrix has entered into a licensing and development agreement with the Lung Cancer Initiative at Johnson & Johnson.
read more
A collaboration with Aldevron, LLC to secure GMP manufacturing capacity for PTC's gene therapy portfolio
read more
Wednesday, April 06, 2016
PGI Drug Discovery has announced that a compound identified through its drug discovery collaboration with Sunovion Pharmaceuticals Inc. has achieved a milestone.
read more